CN114752606B - Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof - Google Patents

Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof Download PDF

Info

Publication number
CN114752606B
CN114752606B CN202210353242.3A CN202210353242A CN114752606B CN 114752606 B CN114752606 B CN 114752606B CN 202210353242 A CN202210353242 A CN 202210353242A CN 114752606 B CN114752606 B CN 114752606B
Authority
CN
China
Prior art keywords
pfar
shewanella
epa
synthesis
transcription regulator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210353242.3A
Other languages
Chinese (zh)
Other versions
CN114752606A (en
Inventor
邱东茹
魏贺红
余佃贞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Hydrobiology of CAS
Original Assignee
Institute of Hydrobiology of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Hydrobiology of CAS filed Critical Institute of Hydrobiology of CAS
Priority to CN202210353242.3A priority Critical patent/CN114752606B/en
Publication of CN114752606A publication Critical patent/CN114752606A/en
Application granted granted Critical
Publication of CN114752606B publication Critical patent/CN114752606B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/64Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409Fatty acids
    • C12P7/6427Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention discloses a transcription regulator PfaR for promoting the synthesis of Shewanella eicosapentaenoic acid (EPA, C20:5ω3) and application thereof, wherein the nucleotide sequence of the transcription factor PfaR is shown as SEQ ID NO.1, and gene knockout and real-time fluorescence quantitative PCR (RT-qPCR) prove that PfaR is taken as a forward regulation factor to participate in the regulation of EPA synthesis at low temperature of Shewanella, and meanwhile, the overexpression of the transcription regulator PfaR can improve EPA content at low temperature of Shewanella. Thus, the transcription regulator PfaR promotes the synthesis of EPA by shiva at low temperature and plays an important role in the improvement of the genetic improvement related to the synthesis of EPA by shiva.

Description

Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof
Technical Field
The invention belongs to the technical field of molecular microorganisms, and particularly relates to application of a Pfa R transcription regulator in promoting EPA synthesis at a low temperature for regulating Shewanella.
Background
Eicosapentaenoic acid (eicosapentaenoic acid, EPA; C20:5ω3) is an omega 3 long chain polyunsaturated fatty acid, and has good effects in lowering blood pressure and cholesterol, maintaining cardiovascular health, treating rheumatoid arthritis, preventing depression, ensuring prenatal health, and treating osteoporosis. The n-3LC-PUFAs are obtained by eating seafood and other products by common consumers, enough n-3LC-PUFAs can be obtained by eating some deep sea fishes frequently, and human serum level surveys find that most people lack the necessary fatty acids.
The demand of people is increasing to cause excessive fishing, the sustainable development of fishery resources is required to be ensured, and the pollution of the environment causes serious pollution of heavy metals and organic matters in fish oil, the fish oil has heavy fishy smell, and the EPA demand in the markets at home and abroad is increasing, so the development of polyunsaturated fatty acid for replacing raw materials in environmental protection and economy is always a subject of great concern. The microorganism is used as an ideal resource for producing n-3LC-PUFAs single-cell oil because of the advantages of high growth speed, low nutrition requirement, simple metabolic regulation and control and the like. Further understanding the EPA synthesis regulatory mechanism of microorganisms helps to develop microbial engineering strains that efficiently synthesize EPA.
At present, a research on a gene cluster for synthesizing EPA of Guan Xiwa bacteria has been reported, the method for improving the EPA content mainly comprises the steps of changing a carbon source nitrogen source, reducing the temperature and externally expressing the gene cluster, but a method for improving the EPA content by using a transcription regulator Pfa R for EPA synthesis has not been reported, and the positive regulation effect of Pfa R in Shewanella EPA synthesis is proved by gene directional knockout and overexpression for the first time.
Disclosure of Invention
In order to increase the yield of EPA synthesized by Shewanella, the present invention provides a transcription regulator PfaR for promoting the synthesis of EPA by Shewanella.
In order to solve the technical problems, the technical scheme adopted by the invention is as follows:
the application of a transcription regulator PfaR in regulation and control of the EPA synthesis of Shewanella, wherein the nucleotide sequence of the regulator PfaR is shown as SEQ ID NO.1, the amino acid sequence is shown as SEQ ID NO.2, and the overexpression of the transcription regulator PfaR in Shewanella can improve the EPA content of Shewanella at low temperature (4-16 ℃).
Specifically, the application includes the following steps:
(1) Constructing an escherichia coli recombinant expression vector of a transcription regulator PfaR;
(2) E.coli recombinant expression vectors of PfaR were transformed into Shewanella, and PfaR overexpressed strains were screened.
Compared with the prior art, the invention has the beneficial effects that:
through functional verification such as gene knockout, RT-qPCR and over-expression, the biological function of the Shewanella PfaR gene is revealed, and a method capable of improving the yield of the Shewanella EPA is provided.
Drawings
FIG. 1 is a graph showing the effect of knockout of Pfa R on the transcriptional level of EPA synthetic gene clusters. W3-18-1 is wild type, delta 2776 is PfaR gene knockout strain.
FIG. 2 shows the decreased EPA content in the PfaR knockout strain delta 2776 at low temperature.
FIG. 3 is a map of plasmid pBBR1 MCS-5.
FIG. 4 shows that overexpression of Pfa R at low temperature can increase EPA content in Shewanella W3-18-1. W3-18-1/p5 represents wild type W3-18-1 carrying empty vector pBBR1MCS-5, delta2776/p 5 represents PfaR gene knockout strain carrying empty vector pBBR1MCS-5, W3-18-1/p5-pfaR represents wild type W3-18-1 carrying over-expression vector pBBR1MCS-5-pfaR.
Detailed Description
The invention is further described below in connection with specific embodiments.
Example 1: cloning of the Shewanella transcription regulator PfaR Gene
1. Shewanella genome extraction
The experimental material was Shewanella W3-18-1 (Shewanella sp.W3-18-1) cultured in laboratory, and the genome extraction was performed using a hundred OMEGA bacterial DNA extraction kit.
2. PfaR Gene cloning
The genome is used as a template, and an upstream primer and a downstream primer PfaR-F of the PfaR gene are designed: GCCATTTTACGA GAGCACGTC and PfaR-R: ACGATGGCAACAGGCATATCT as primers for the PCR reaction. PCR amplification and reaction conditions were all carried out according to the instructions. After the reaction is finished, the PCR product is separated by 1% agarose gel electrophoresis to obtain a product with the length of about 1050bp, and after purification and recovery, the product is sent to a biological engineering for sequencing, the result is shown as SEQ ID NO.1, the length of the nucleotide sequence is 870bp, the coded protein sequence is shown as SEQ ID NO.2, and the protein consists of 289 amino acids.
Example 2: functional verification of the Shewanella PfaR Gene
1. Effects of PfaR on EPA Synthesis-related genes
1.1 knockout of the PfaR Gene
The pfaR gene in Shewanella W3-18-1 is knocked out by utilizing a gene site-directed knockout technology, and a PfaR upstream and downstream primer PfaR-5O is designed: accgcatgcgatatcgagctcTCGAGCCCTGTTTGTTGCTT, pfaR-5I: AAAGAGTCTCCACGGGTCGAGAGTCTCATCTCAGGCGTGG, pfaR-3I: CCACGCCTGAGATGAGACTCTCGACCCGTGGAGACTCTTT and PfaR-3O: gtggaattcccgggagagctcCTTTGGCGACAATCAGCGAC (italic lower case as homology arm), first, using genome as template, using Pfa R-5O and Pfa R-5I, pfa R-3O and Pfa R-3I as primer to amplify 5 'and 3' fragment, then using 5 'and 3' fragment as template, using Pfa R-5O and Pfa R-3O as primer to make cross-server PCR to obtain Pfa R deletion target fragment ΔpfaR. Single cleavage SacI-treated pDS3.0 (Wan, verBerkmoes et al 2004) was recombined with the fragment of interest ΔpfaR using the non-ligase dependent single fragment rapid cloning kit of Nanjinopran Biotechnology, inc., and ligation products pDS3.0- ΔpfaR transformed E.coli WM3064.
Shewanella W3-18-1 wild type was conjugated to pDS 3.0-. DELTA.pfaR/WM 3064 using LB-Dap (Meso-2, 5-diaminopimelic Acid, diaminopimelic acid, 50 mg/L), single-crossover screening was performed using LB-Gm (gentamicin) 15mg/L, and double-crossover screening was performed using LB-10% S (sucrose, W/v). Mutant Δpfar was verified using both pfaR-5O and pfaR-3O assays.
1.2 Effect of PfaR on EPA synthetic Gene Cluster expression
Culturing wild-type Shewanella W3-18-1 and mutant strain delta 2776 to OD at 28℃using LB liquid medium 600 About 0.6 to 0.8, transferring to a low temperature of 16 ℃, sampling after 8 hours, extracting RNA, and carrying out RT-qPCR. RNA extraction and reverse transcription were performed according to the kit instructions. The primers used for RT-qPCR are shown in Table 1, and the reference gene is the 16SrRNA gene.
TABLE 1 primers used for RT-qPCR
As a result, as shown in FIG. 1, the EPA synthetic gene cluster in the Pfa R gene knockout strain Δ2776 at low temperature was transcribed to a low level after knocking out Pfa R, and it was confirmed that Pfa R affects the EPA synthetic gene cluster transcription at low temperature and is a positive regulator.
1.3 changes in EPA content after PfaR knockout
Activation of Shewanella with LB liquid MediumWild-type and mutant strain Delta 2776,1% of W3-18-1 were transferred to modified 2216 medium (5 g peptone in 1L, 2g yeast extract, 0.02g Na) 2 HPO 4 ,0.05gMgSO 4 ·7H 2 O,1g glucose, 20g sea salt) to OD600 of about 0.6-0.8, culturing at 4 ℃,16 ℃ and 28 ℃ for 24h and 48h respectively, and collecting the thalli. After freeze-drying, 20mg of the cells were weighed and subjected to methyl esterification, and the EPA content was measured by GC-MS analysis, and the procedure was as follows: the sample inlet and detector temperatures were maintained at 250 ℃ and 270 ℃, respectively, the oven temperature was increased from 150 ℃ to 240 ℃, the temperature increase rate was 6 ℃/min, and high purity helium was used as the carrier gas. As shown in FIG. 2, the decrease in the amount of Shewanella EPA synthesized at low temperature (4 ℃ C., 16 ℃ C.) after PfaR knockout was demonstrated.
The methyl esterification adopts a sodium hydroxide-methanol method, and comprises the following specific steps:
(1) Weighing about 20mg of cells, grinding the cells into powder, and adding the powder into a COD digestion tube;
(2) 1ml of sodium hydroxide-methanol solution (45 g of sodium hydroxide in 150ml of methanol and 150ml of water) was added thereto, followed by shaking by vortexing for 10s;
(3) Boiling for 5min, swirling for 10s again, and boiling for 25min again;
(4) Cold cutting to room temperature, adding 2ml of hydrochloric acid-methanol-water solution (39:55:26, volume ratio) and mixing well;
(5) Water bath at 80deg.C for 10min, and rapidly cooling with cold water;
(6) 1.25ml of n-hexane is added, the mixture is gently shaken for 10min, 3ml of 1.2% NaOH solution is added, the mixture is gently shaken for 5min, and 300 mu L of saturated NaCl solution is added, the mixture is gently shaken for 5min;
(7) Centrifuging at 2000rpm for 3min, collecting upper layer, and collecting upper layer with anhydrous MgSO 4 After dehydration, analysis was performed by GC-MS.
2. Shewanella PfaR gene overexpression
2.1 construction of the overexpression vector
The overexpression vector used in the invention is pBBR1MCS-5 (Kovach, phillips et al 1994), the vector map is shown in FIG. 3. The vector is linearized by selecting a suitable endonuclease for double cleavage, and the two endonucleases used in the present invention are KpnI enzyme and HindIII enzyme. Design of homologous recombination primer 2776-p5 (O) -F (KpnI): agggaacaaaagctgggtaccATGACCACTAGCGCAACTGATGAAAAGCCC and 2776-p5 (O) -R (HindIII): caggaattcgatatcaagcttTCATAAAGAGTCTCCACGGGTCGACCTG (italic lowercase homology arm) the PfaR gene was obtained by amplification using the genome as a template.
The recombination reaction uses a non-ligase dependent single fragment rapid cloning kit of Nanjinopran biotechnology company, a positive strain is obtained by converting a ligation product pBBR1MCS-5-PfaR into escherichia coli WM3064, the positive strain is named WM3064/pBBR1MCS-5-PfaR, and plasmid sequencing is obtained by culturing the positive strain and extracting.
2.2 transformation of Shewanella by conjugation
Shewanella W3-18-1 wild type was cultured simultaneously, mutant Delta2776, WM3064/pBBR1MCS-5-PfaR and WM3064/pBBR1MCS-5, and after the W3-18-1 wild type, mutant Delta 27776 and WM3064/pBBR1MCS-5-PfaR and WM3064/pBBR1MCS-5 were ligated with WM3064/pBBR1MCS-5 at LB-Dap50mg/L for 8 hours, positive clones were obtained by screening with LB-Gm15mg/L, respectively.
2.3 phenotype detection of overexpressing strains
Culturing W3-18-1/pBBR1MCS-5, delta 2776/pBBR1MCS-5, W3-18-1/pBBR1MCS-5-PfaR with modified 2216 culture medium (Gm 15 mg/L), culturing at 16 ℃ for 24 hours, collecting thalli, freeze drying, weighing 20mg for methyl esterification, and determining EPA content by GC-MS analysis, wherein the methyl esterification and GC-MS analysis are the same. As shown in FIG. 4, it was demonstrated that overexpression of Pfa R at low temperature increased EPA content in Shewanella W3-18-1.
Reference to the literature
Kovach,M.E.,R.W.Phillips,P.H.Elzer,R.M.Roop,2nd and K.M.Peterson(1994)."pBBR1MCS:a broad-host-range cloning vector."Biotechniques 16(5):800-802.
Wan,X.F.,N.C.VerBerkmoes,L.A.McCue,D.Stanek,H.Connelly,L.J.Hauser,L.Y.Wu,X.D.Liu,T.F.Yan,A.Leaphart,R.L.Hettich,J.Z.Zhou and D.K.Thompson(2004)."Transcriptomic and proteomic characterization of the fur modulon in the metal-reducing bacterium Shewanella oneidensis."Journal of Bacteriology 186(24):8385-8400.
Sequence listing
<110> institute of aquatic organisms at national academy of sciences
<120> transcriptional regulator PfaR promoting Shewanella EPA synthesis and use thereof
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 870
<212> DNA
<213> Artificial sequence (Artificial Sequence)
<400> 1
atgaccacta gcgcaactga tgaaaagccc tcggagaaaa cgggaaagct tggagcgagt 60
cgagaagaaa agcacactca atcgaggcat agcaatgcga ctaccacgcc tgagatgaga 120
ctctttattc agcaatcgga tctgagtgtg agtcagcttg ccaaaattct aaatatcacc 180
gaagccacag ttcgcaaatg gcgtaaacgt gagtcgattg ttgattgtcc caatactccg 240
catcacctca ataccacgct cacaccgatg gaagaatatg tggttgtcgg cctaagatac 300
caattaaaac tccccttaga ccggctacta aaagccactc aaacctttat taatcccaat 360
gtgtcgcgct ccggccttgc ccgctgctta aagcgctacg gcatatcgcg gctcgatgaa 420
tttgaagcac cacaagtacc cgaacgctat tttaatcaat tgcctgtgac gcaaggcagc 480
gatatccaaa cctatacggt caatccagaa accttggcca aagccctcgc attgccgagt 540
accgacggca atactgtggt gcaagtggtg tcactcacca taccgccgca actcactgag 600
caagcgccaa gctcagtact attaggcgta gacacagcaa gtgattggat ttacctcgat 660
atttatcaag acagcaatac ccaagcgacc aatagatata tcgcctatgt cctcagacat 720
gggccgtttc atttacgaaa gttgctcgtt cgcaactatc acaccttctt agcccgtttt 780
cccggtgccc atggcacgcc aaagacaagc gcggctggat cccaaaacaa ggtcaccgta 840
tccaggtcga cccgtggaga ctctttatga 870
<210> 2
<211> 289
<212> PRT
<213> Artificial sequence (Artificial Sequence)
<400> 2
Met Thr Thr Ser Ala Thr Asp Glu Lys Pro Ser Glu Lys Thr Gly Lys
1 5 10 15
Leu Gly Ala Ser Arg Glu Glu Lys His Thr Gln Ser Arg His Ser Asn
20 25 30
Ala Thr Thr Thr Pro Glu Met Arg Leu Phe Ile Gln Gln Ser Asp Leu
35 40 45
Ser Val Ser Gln Leu Ala Lys Ile Leu Asn Ile Thr Glu Ala Thr Val
50 55 60
Arg Lys Trp Arg Lys Arg Glu Ser Ile Val Asp Cys Pro Asn Thr Pro
65 70 75 80
His His Leu Asn Thr Thr Leu Thr Pro Met Glu Glu Tyr Val Val Val
85 90 95
Gly Leu Arg Tyr Gln Leu Lys Leu Pro Leu Asp Arg Leu Leu Lys Ala
100 105 110
Thr Gln Thr Phe Ile Asn Pro Asn Val Ser Arg Ser Gly Leu Ala Arg
115 120 125
Cys Leu Lys Arg Tyr Gly Ile Ser Arg Leu Asp Glu Phe Glu Ala Pro
130 135 140
Gln Val Pro Glu Arg Tyr Phe Asn Gln Leu Pro Val Thr Gln Gly Ser
145 150 155 160
Asp Ile Gln Thr Tyr Thr Val Asn Pro Glu Thr Leu Ala Lys Ala Leu
165 170 175
Ala Leu Pro Ser Thr Asp Gly Asn Thr Val Val Gln Val Val Ser Leu
180 185 190
Thr Ile Pro Pro Gln Leu Thr Glu Gln Ala Pro Ser Ser Val Leu Leu
195 200 205
Gly Val Asp Thr Ala Ser Asp Trp Ile Tyr Leu Asp Ile Tyr Gln Asp
210 215 220
Ser Asn Thr Gln Ala Thr Asn Arg Tyr Ile Ala Tyr Val Leu Arg His
225 230 235 240
Gly Pro Phe His Leu Arg Lys Leu Leu Val Arg Asn Tyr His Thr Phe
245 250 255
Leu Ala Arg Phe Pro Gly Ala His Gly Thr Pro Lys Thr Ser Ala Ala
260 265 270
Gly Ser Gln Asn Lys Val Thr Val Ser Arg Ser Thr Arg Gly Asp Ser
275 280 285
Leu

Claims (2)

1. A method for increasing EPA content in Shewanella W3-18-1 is characterized in that a transcription regulator PfaR is overexpressed in Shewanella W3-18-1, and the nucleotide sequence of the regulator PfaR is shown as SEQ ID NO. 1.
2. The method according to claim 1, wherein the Shewanella over-expressing the transcription regulator PfaR is cultured at 4-16 ℃.
CN202210353242.3A 2022-04-02 2022-04-02 Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof Active CN114752606B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210353242.3A CN114752606B (en) 2022-04-02 2022-04-02 Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210353242.3A CN114752606B (en) 2022-04-02 2022-04-02 Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof

Publications (2)

Publication Number Publication Date
CN114752606A CN114752606A (en) 2022-07-15
CN114752606B true CN114752606B (en) 2023-09-26

Family

ID=82330113

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210353242.3A Active CN114752606B (en) 2022-04-02 2022-04-02 Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof

Country Status (1)

Country Link
CN (1) CN114752606B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101942469A (en) * 2009-07-07 2011-01-12 国家海洋局第三海洋研究所 Shewanella EPA synthetic gene cluster and gene engineering bacterium containing same
CN101942409A (en) * 2009-07-07 2011-01-12 国家海洋局第三海洋研究所 Shewanella piezotolerans genetic engineering bacteria for producing eicosapentaenoic acid (EPA) in high yield

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3140408A4 (en) * 2014-05-08 2018-01-03 Scfm Ventures, LLC Method for optimizing production of eicosapentaenoic acid (epa) ina recombinant host

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101942469A (en) * 2009-07-07 2011-01-12 国家海洋局第三海洋研究所 Shewanella EPA synthetic gene cluster and gene engineering bacterium containing same
CN101942409A (en) * 2009-07-07 2011-01-12 国家海洋局第三海洋研究所 Shewanella piezotolerans genetic engineering bacteria for producing eicosapentaenoic acid (EPA) in high yield

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Characterization and Application of Marine Microbial Omega-3 Polyunsaturated Fatty Acid Synthesis;Marco N. Allemann et al;《Methods in Enzymology》;第605卷;参见第22页第1段以及图2 *
transcriptional regulator [Shewanella sp. W3-18-1];无;《NCBI》;参见标题、FEATURES以及ORIGIN *

Also Published As

Publication number Publication date
CN114752606A (en) 2022-07-15

Similar Documents

Publication Publication Date Title
CN102245779A (en) Biosynthesis of commodity chemicals
CN109777793B (en) GDSL lipase, genetically engineered bacterium and application thereof
CN104651287A (en) Engineering bacterium for synthesizing glycosylglycerol and application thereof
JP2003520580A (en) Enzymes and genes for producing vanillin
CN109266596A (en) Efficiently utilize the Escherichia coli recombinant strain and its construction method of fatty acid synthesis glycine and application
CN113755354A (en) Recombinant saccharomyces cerevisiae for producing gastrodin by using glucose and application thereof
CN116286900A (en) Acetate osmotic enzyme A gene RkAcpa and application thereof
CN105713883B (en) L-proline-4-hydroxylase and application thereof
CN101748069A (en) recombinant blue-green algae
CN106754979B (en) Gene for regulating and controlling long-chain fatty acid transport of candida tropicalis and application of gene
CN114752606B (en) Transcription regulator PfaR for promoting Shewanella EPA synthesis and application thereof
CN110592035B (en) Carbonyl reductase mutant, recombinant expression vector and application of carbonyl reductase mutant in production of chiral alcohol
CN113249240B (en) Saccharomyces cerevisiae for high yield of hydroxytyrosol and construction method thereof
CN113512100B (en) Application of LipR protein and coding gene thereof in regulation and control of DHA and oil synthesis
CN108753810B (en) Application of transcriptional regulatory protein gene ORF2
CN112553221B (en) Bifunctional thiolase gene MvaE, expression vector, recombinant strain and application thereof
CN109097315B (en) Genetically engineered bacterium for high-yield lipopeptide and construction method and application thereof
CN108251406B (en) L-rhamnose-1-phosphate aldolase and application thereof in catalytic synthesis of rare sugar D-psicose
CN112852847A (en) Recombinant saccharomyces cerevisiae strain and construction method and application thereof
CN102277327B (en) Colon bacillus for over-expressing RimL and application on preparing N-extrasin alpha acetylate
CN118207171B (en) Biotin ligase mutant and its use in biotin production
CN113652409B (en) Novel glycyrrhetinic acid glucuronyl transferase mutant and application thereof
CN113481177B (en) Starch branching enzyme mutant with enhanced extracellular secretion capacity
CN109957556B (en) Preparation method of S-adenosylmethionine
CN113667686B (en) Escherichia coli recombinant bacteria for efficiently synthesizing inositol by utilizing glucose, construction method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant